XoMotion-R Exoskeleton for Spinal Cord Injury

YO
JM
Overseen ByJessica M D'Amico, Scientific Program Lead and Assistant Professor, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new device called the XoMotion-R, a self-balancing exoskeleton that helps people with spinal cord injuries walk without using their hands. The research targets individuals who can move their legs but struggle with weak upper body strength, preventing the use of walkers or crutches. Participants will use the exoskeleton during rehab to determine if it improves walking and overall recovery. The study seeks individuals hospitalized or undergoing outpatient rehab who wish to enhance their walking ability. As an unphased trial, this study offers a unique opportunity to explore innovative rehabilitation technology and potentially enhance the recovery journey.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the XoMotion-R exoskeleton is safe for spinal cord injury patients?

Research has shown that the XoMotion-R exoskeleton is generally safe for people with spinal cord injuries (SCI). Studies have used exoskeletons for walking training without major safety issues. Research on similar devices indicates they are well-tolerated and can improve walking ability. Most users do not experience serious side effects, though some may feel mild discomfort as they adjust to the device.

One study highlighted that exoskeletons can encourage neuroplasticity, the brain's ability to adapt and change, and help reduce complications from SCI. These findings suggest that using an exoskeleton like the XoMotion-R can be a safe part of rehabilitation. While each person may respond differently, current evidence supports the safety of this technology for those looking to regain mobility after a spinal cord injury.12345

Why are researchers excited about this trial?

Researchers are excited about the XoMotion-R Exoskeleton because it offers a unique approach to spinal cord injury rehabilitation. Unlike traditional therapies that often rely on passive exercises or manual assistance, the XoMotion-R actively engages patients in walking with a self-balancing exoskeleton, promoting early weight-bearing and postural control. This exoskeleton allows for individualized training that adapts to a patient's progress, potentially accelerating recovery and improving independence. Additionally, the focus on functional activities like sit-to-stand transitions and obstacle negotiation could enhance daily living skills and quality of life in ways that standard therapies might not.

What evidence suggests that the XoMotion-R exoskeleton is effective for spinal cord injury?

Research has shown that training with exoskeletons can greatly improve walking independence for people with incomplete spinal cord injuries. In this trial, participants will join either an inpatient or outpatient group, both using the XoMotion-R exoskeleton. Studies have found that robotic therapy, like the XoMotion-R, enhances walking ability and quality of life more than standard treatments alone. In one study, participants randomly assigned to different groups showed better lower body movement when using exoskeletons. Other research also supports that these devices can help improve walking over time. Overall, the evidence suggests that exoskeletons are a promising tool for enhancing mobility in people with spinal cord injuries.14678

Who Is on the Research Team?

JM

Jessica M D'Amico, PhD

Principal Investigator

University of Alberta and Alberta Health Services

Are You a Good Fit for This Trial?

This trial is for individuals with a Spinal Cord Injury (SCI) who have an American Spinal Injury Association Impairment Scale rating of B-D. It's aimed at those wanting to improve walking abilities and are either inpatient or outpatient participants willing to use the XoMotion-R exoskeleton during rehabilitation.

Inclusion Criteria

I am currently hospitalized and expected to walk on my own within a year.
I need the XoMotion device to help me walk better.
I have a spinal cord injury classified as AIS C or D if hospitalized, or AIS B-D if not.

Exclusion Criteria

SCI AIS A

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Inpatient Treatment

Inpatient participants receive locomotor therapy with the XoMotion-R for 30-45 minutes, 2-3 times per week, focusing on early weight-bearing and postural control

6 weeks
2-3 visits per week (in-person)

Outpatient Treatment

Outpatient participants receive locomotor therapy with the XoMotion-R for 30-45 minutes, 2-3 times per week, focusing on increased walking distance and community-based ambulation

6 weeks
2-3 visits per week (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • XoMotionR

Trial Overview

The study tests the XoMotion-R, a self-balancing exoskeleton designed for hands-free walking by people with certain levels of SCI. The goal is to see if it can help improve their ability to walk and reduce hospital stay, complications, and long-term disability.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Outpatient SCI GroupExperimental Treatment1 Intervention
Group II: Inpatient SCI GroupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

Praxis Spinal Cord Institute

Collaborator

Trials
5
Recruited
80+

Citations

Xo-Motion R Exoskeleton in SCI-Adoption Study

This study seeks to determine the safety and feasibility of the XoMotion-R, a self-balancing exoskeleton that allows people with American Spinal ...

Effects of an exoskeleton robot on motor function in patients ...

Exoskeleton-based training improves walking independence in incomplete spinal cord injury patients: results from a randomized controlled trial.

The use of exoskeleton robotic training on lower extremity ...

Robotic Therapy could improve ambulation/quality of life in patients with spinal cord injuries compared to the standard treatment only.

Exoskeleton home and community use in people with ...

Walking improvement in chronic incomplete spinal cord injury with exoskeleton robotic training (WISE): a randomized controlled trial.

Comparative efficacy of robotic exoskeleton and conventional ...

This meta-analysis aims to explore the effectiveness of lower limb robotic exoskeletons in rehabilitation training for patients with SCI. Our ...

Exoskeletons for Mobility after Spinal Cord Injury - PMC - NIH

Gait training after spinal cord injury: Safety, feasibility and gait function following 8 weeks of training with the exoskeletons from Ekso ...

Exoskeleton-Assisted Rehabilitation and Neuroplasticity in ...

Exoskeleton serves as an emerging and promising tool for rehabilitation, especially in promoting neuroplasticity and alleviating SCI-related complications.

Frontiers | Safety and Feasibility of a Novel Exoskeleton for ...

The advent of exoskeletal robotic technology can benefit the spinal cord injury population in three ways: (1) extensive repetitions of walking ...